ChemicalBook >> CAS DataBase List >>HJC-0123

HJC-0123

CAS No.
1430420-02-2
Chemical Name:
HJC-0123
Synonyms
HJC-0123;4-Quinolinecarboxamide, N-(1,1-dioxidobenzo[b]thien-6-yl)-2-phenyl-
CBNumber:
CB42731067
Molecular Formula:
C24H16N2O3S
Molecular Weight:
412.46
MDL Number:
MOL File:
1430420-02-2.mol
MSDS File:
SDS
TDS File:
TDS
Last updated:2026-07-27 17:00:41

HJC-0123 price

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
ChemScene CS-0066320 HJC0123 99.06% 1430420-02-2 5mg $81 2026-06-04 Buy
ChemScene CS-0066320 HJC0123 99.06% 1430420-02-2 10mg $130 2026-06-04 Buy
ChemScene CS-0066320 HJC0123 99.06% 1430420-02-2 25mg $260 2026-06-04 Buy
ChemScene CS-0066320 HJC0123 99.06% 1430420-02-2 50mg $417 2026-06-04 Buy
ChemScene CS-0066320 HJC0123 99.06% 1430420-02-2 100mg $666 2026-06-04 Buy
Product number Packaging Price Buy
CS-0066320 5mg $81 Buy
CS-0066320 10mg $130 Buy
CS-0066320 25mg $260 Buy
CS-0066320 50mg $417 Buy
CS-0066320 100mg $666 Buy

HJC-0123 Chemical Properties, Uses, Production

Description

Downregulate phosphorylation of STAT3, increase the expression of cleaved caspase-3, inhibit cell cycle progression and promote apoptosis in breast and pancreatic cancer cells with low micromolar to nanomolar IC50 values. Furthermore, HJC-0123 significantly suppressed estrogen receptor (ER)-negative breast cancer MDA-MB-231 xenograft tumor growth in vivo (p.o.), indicating its great potential as an efficacious and orally bioavailable drug candidate for human cancer therapy.

Uses

HJC0123 is a STAT3 inhibitor. HJC0123 inhibits the proliferation of hepatic stellate cells and induces cell cycle arrest and apoptosis. HJC0123 reduces the phosphorylation, nuclear translocation and transcriptional activities of STAT3, increases the production of IL-6, inhibits the phosphorylation of Smad2/3 and down-regulates SOCS3. HJC0123 can be used in the study of liver fibrosis[1].

IC 50

STAT3; IL-6

References

[1] Nunez Lopez O, et al. STAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis. RSC Adv. 2016;6(102):100652-100663. DOI:10.1039/C6RA17459K

HJC-0123 Preparation Products And Raw materials

Raw materials

Preparation Products

HJC-0123 Suppliers

Global Suppliers ( 5)
Supplier Tel Email Country ProdList Advantage
BOC Sciences 1-631-485-4226; 16314854226 info@bocsci.com United States 9920 65
Shanghai Beckham Medical Technology Co., Ltd 13816613772 huahero21@sina.com China 2994 55
Guangzhou Younan Technology Co., Ltd 020-82000279 18988941452 YN_research@163.com China 2984 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29873 58
TargetMol Chemicals Inc. 13564774135 marketing@targetmol.com United States 19950 58

View Latest Price from HJC-0123 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
HJC-0123 pictures 2026-07-27 HJC-0123
1430420-02-2
$1520.00-2500.00 10g TargetMol Chemicals Inc.
  • HJC-0123 pictures
  • HJC-0123
    1430420-02-2
  • $1520.00-2500.00
  • TargetMol Chemicals Inc.
HJC-0123 4-Quinolinecarboxamide, N-(1,1-dioxidobenzo[b]thien-6-yl)-2-phenyl- 1430420-02-2